Back to search

Article

Antibodies to SARS-CoV-2 are associated with protection against reinfection

2020-11-19

Abstract excerpt

<h4>Background</h4> It is critical to understand whether infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) protects from subsequent reinfection. <h4>Methods</h4> We investigated the incidence of SARS-CoV-2 PCR-positive results in seropositive and seronegative healthcare workers (HCWs) attending asymptomatic and symptomatic staff testing at Oxford University Hospitals, UK. Baseline antibod...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ada5a869-f434-5f88-ae34-882319f67dc5
DOI
10.1101/2020.11.18.20234369
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antibodies to SARS-CoV-2 are associated with protection against reinfectionDOI 10.1101/2020.11.18.20234369
Nucleocapsid and spike antibody responses post virologically confirmed SARS-CoV-2 infection: An observational analysis in the Virus Watch community cohortSemantic proximity
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort studySemantic proximity
The Protective Effect of SARS-CoV-2 Antibodies in Scottish Healthcare WorkersSemantic proximity
An immune correlate of SARS-CoV-2 infection and severity of reinfectionsSemantic proximity
Incidence of Severe Acute Respiratory Syndrome Coronavirus-2 infection among previously infected or vaccinated employeesSemantic proximity
Influencing factors of Anti-SARS-CoV-2-Spike IgG antibody titres in healthcare workers – A cross-section studySemantic proximity
Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severitySemantic proximity
SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody DynamicsSemantic proximity
Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modellingSemantic proximity
Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severitySemantic proximity
Antibody response to SARS-CoV-2 infection in humans: a systematic reviewSemantic proximity
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infectionSemantic proximity
Select a neighboring publication to make it the new centre.